Six years ago, we set out with a bold vision: build a contract research organization that offers exceptional bioconjugation and analytical services to biotech and large pharma.
Over the past six years, we have:
Prepared and characterized numerous bioconjugates (conventional & site-specific) for early-stage evaluation
Developed many bioconjugate candidates of varying complexities (process and analytics) from lead selection to regulatory toxicology
Developed standalone analytical methods
Qualified/validated analytical methods and tech transfer to client/CMO
Performed GMP analyses using qualified/validated methods
Multiple repeat clients US biotech + large pharma
Referrals from major CDMOs, biotech and large pharma
What Differentiates US from our Competitors:
Comprehensive experience and expertise with many bioconjugate platforms including, but not limited to, ADC, AOC, Protein-polysaccharide conjugate, Peptide conjugate, Steroid conjugate
Aggressive development timelines, exceptional quality and customer satisfaction
Fully GMP-compliant analytical lab in the US
IND/BLA regulatory filing experience
We are incredibly grateful to our employees and clients for believing in our vision and contributing to our success.
This anniversary is not just a celebration of where we have been, it is a commitment to where we are going.
Thank you for being part of our journey. Here is to the future!